Intrinsic T-cell regulator miR-142-3p/5p-a novel therapeutic target?

被引：3
|
作者：
Dolff, Sebastian [1 ]
Abdulahad, Wayel H. [2 ]
Wilde, Benjamin [3 ]
机构：
[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Infect Dis, Essen, Germany
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands
[3] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany
来源：
CELLULAR & MOLECULAR IMMUNOLOGY | 2021年 / 18卷 / 02期
关键词：
D O I：
10.1038/s41423-019-0317-y
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：508 / 509
页数：2
相关论文
共 50 条
  • [21] miR-142-3p is essential for hematopoiesis and affects cardiac cell fate in zebrafish
    Nishiyama, Takahiko
    Kaneda, Ruri
    Ono, Tomohiko
    Tohyama, Shugo
    Hashimoto, Hisayuki
    Endo, Jin
    Tsuruta, Hikaru
    Yuasa, Shinsuke
    Ieda, Masaki
    Makino, Shinji
    Fukuda, Keiichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 425 (04) : 755 - 761
  • [22] T cell exosome derived miR-142-3p impairs glandular cell function in Sjogren's syndrome
    Cortes-Troncoso, Juan
    Jang, Shyh-Ing
    Perez, Paola
    Hidalgo, Jorge
    Ikeuchi, Tomoko
    Greenwell-Wild, Teresa
    Warner, Blake M.
    Moutsopoulos, Niki M.
    Alevizos, Ilias
    JCI INSIGHT, 2020, 5 (09)
  • [23] Circulating miR-142-3p levels in patients with systemic sclerosis
    Makino, K.
    Jinnin, M.
    Kajihara, I.
    Honda, N.
    Sakai, K.
    Masuguchi, S.
    Fukushima, S.
    Inoue, Y.
    Ihn, H.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2012, 37 (01) : 34 - 39
  • [24] Increased miR-142-3p Expression Might Explain Reduced Regulatory T Cell Function in Granulomatosis With Polyangiitis
    Dekkema, Gerjan J.
    Bijma, Theo
    Jellema, Pytrick G.
    Van Den Berg, Anke
    Kroesen, Bart-Jan
    Stegeman, Coen A.
    Heeringa, Peter
    Abdulahad, Wayel H.
    Sanders, Jan-Stephan
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [25] miR-142-3p as a novel biomarker for predicting poor prognosis in renal cell carcinoma patients after surgery
    Peng, Xiqi
    Pan, Xiang
    Liu, Kaihao
    Zhang, Chunduo
    Zhao, Liwen
    Li, Hang
    Guan, Xin
    Xu, Weijie
    Xu, Jinling
    Zhang, Fangting
    Lai, Yongqing
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2019, 34 (03): : 302 - 308
  • [26] Triptolide Induces the Expression of miR-142-3p: A Negative Regulator of Heat Shock Protein 70 and Pancreatic Cancer Cell Proliferation
    MacKenzie, Tiffany N.
    Mujumdar, Nameeta
    Banerjee, Sulagna
    Sangwan, Veena
    Sarver, Aaron
    Vickers, Selwyn
    Subramanian, Subbaya
    Saluja, Ashok K.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (07) : 1266 - 1275
  • [27] Expression Profiles of miR-22-5p and miR-142-3p Indicate Hashimoto's Disease and Are related to Thyroid Antibodies
    Trummer, Olivia
    Foessl, Ines
    Schweighofer, Natascha
    Arifi, Edi
    Haudum, Christoph W.
    Reintar, Sharmaine
    Pilz, Stefan
    Theiler-Schwetz, Verena
    Trummer, Christian
    Zirlik, Andreas
    Schmidt, Albrecht
    Colantonio, Caterina
    Kolesnik, Ewald
    Verheyen, Nicolas
    Pieber, Thomas R.
    Obermayer-Pietsch, Barbara
    GENES, 2022, 13 (02)
  • [28] miR-142-3p promotes osteoblast differentiation by modulating Wnt signaling
    Hu, Weihua
    Ye, Yaping
    Zhang, Weikai
    Wang, Jiang
    Chen, Anmin
    Guo, Fengjing
    MOLECULAR MEDICINE REPORTS, 2013, 7 (02) : 689 - 693
  • [29] MiR-142-3p is a paracrine mediator between T cells and endothelium during allograft rejection
    Gupta, Shashi K.
    Thum, Thomas
    CARDIOVASCULAR RESEARCH, 2017, 113 (05) : 431 - 433
  • [30] Effect of miR-142-3p on the M2 Macrophage and Therapeutic Efficacy Against Murine Glioblastoma
    Xu, Shuo
    Wei, Jun
    Wang, Fei
    Kong, Ling-Yuan
    Ling, Xiao-Yang
    Nduom, Edjah
    Gabrusiewicz, Konrad
    Doucette, Tiffany
    Yang, Yuhui
    Yaghi, Nasser K.
    Fajt, Virginia
    Levine, Jonathan M.
    Qiao, Wei
    Li, Xin-Gang
    Lang, Frederick F.
    Rao, Ganesh
    Fuller, Gregory N.
    Calin, George A.
    Heimberger, Amy B.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (08):
12345